Capital World Investors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,458,000
Closed -$176M 541
2023
Q1
$176M Hold
1,458,000
0.04% 288
2022
Q4
$167M Buy
1,458,000
+400
+0% +$44.1K 0.04% 296
2022
Q3
$148M Hold
1,457,600
0.03% 298
2022
Q2
$148M Buy
1,457,600
+300
+0% +$32.7K 0.03% 301
2022
Q1
$170M Hold
1,457,300
0.03% 317
2021
Q4
$167M Buy
+1,457,300
New +$166M 0.03% 326
2020
Q4
Sell
-1,491,091
Closed -$167M 587
2020
Q3
$167M Buy
1,491,091
+411,305
+38% +$46.1M 0.04% 280
2020
Q2
$113M Buy
+1,079,786
New +$116M 0.03% 299

Other funds holding BSX.PRA

Capital World Investors's BSX.PRA Position: Q2 2023 in Review

Capital World Investors sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 1,458,000 shares — an estimated $176M sold.

Capital World Investors first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $176M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Capital World Investors reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Capital World Investors sold 1,458,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $176M.
  • Capital World Investors first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
  • Capital World Investors's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $176M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Capital World Investors's 13F filing for Q2 2023, filed 11 Aug 2023.